Centre expands startup definition to include deep-tech ventures

91

India has revised its startup definition to formally recognise deep‑tech ventures, extending policy benefits to research‑intensive, long‑gestation innovation across strategic sectors.

Article

The Centre has rewritten India’s official startup definition to explicitly recognise deep‑tech ventures, marking a significant policy shift aimed at supporting research‑heavy, long‑gestation innovation. The revised framework is expected to bring startups working in areas such as artificial intelligence, semiconductors, biotechnology, space, defence technologies, and advanced materials within the ambit of government incentives and support schemes.

Until now, India’s startup policy largely focused on age, turnover, and innovation criteria that were better suited to consumer internet and services‑led companies. Deep‑tech ventures — which typically require longer development cycles, higher capital investment, and extended periods before commercialisation — often struggled to qualify for benefits designed around faster‑scaling business models.

Under the updated definition, the emphasis shifts from rapid revenue growth to the nature of innovation, recognising startups that are built on scientific research, engineering breakthroughs, or proprietary intellectual property. This change is expected to improve access to tax exemptions, funding programmes, public procurement opportunities, and regulatory relaxations for deep‑tech founders.

The policy rewrite also reflects the government’s broader strategic priorities. As India pushes for technological self‑reliance in critical sectors — from chip design and clean energy to space technologies — deep‑tech startups are increasingly seen as national assets rather than niche experiments. Aligning startup recognition with these goals helps channel capital and institutional support into areas with high strategic and economic impact.

For investors, the revised definition offers greater clarity and confidence. Formal recognition lowers regulatory uncertainty and signals long‑term policy backing, which is crucial for venture capital and patient capital funds operating in deep‑tech domains. For founders, it reduces the structural mismatch between policy expectations and the realities of building science‑led companies.

However, the effectiveness of the change will depend on implementation. Clear guidelines, consistent interpretation across ministries, and timely access to benefits will determine whether the revised definition translates into real support on the ground or remains largely symbolic.